Structure activity relationships of lysophospholipid mediators.
Lynch
K R
KR
Department of Pharmacology, University of Virginia, Charlottesville, USA. krl2z@virginia.edu
Macdonald
T L
TL
D004345:Drug Industry; D008246:Lysophospholipids / Q000378:metabolism* / Q000494:pharmacology; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid; D015398:Signal Transduction; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology
D008246:Lysophospholipids; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid; C005356:sphingosine phosphorylcholine; D010767:Phosphorylcholine; C060506:sphingosine 1-phosphate; D013110:Sphingosine